Bibliography
- Hamilton JG. Needle phobia: a neglected diagnosis. J Fam Pract 1995;41:169-75
- Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance. Diabetes Care 1997;20:292-8
- Korytkowski M, Niskanen L, Asakura T. FlexPen: addressing issues of confidence and convenience in insulin delivery. Clin Ther 2005;27(Suppl B):S89-100
- Mollema ED, Snoek FJ, Ader HJ, Insulin-treated diabetes patients with fear of self-injecting or fear of self-testing: psychological comorbidity and general well-being. J Psychosom Res 2001;51:665-72
- Mollema ED, Snoek FJ, Heine RJ, Phobia of self-injecting and self-testing in insulin-treated diabetes patients: opportunities for screening. Diabet Med 2001;18:671-4
- Keith K, Nicholson D, Rogers D. Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump. Clin Pediatr (Phila) 2004;43:69-74
- Lteif AN, Schwenk WF. Accuracy of pen injectors versus insulin syringes in children with type 1 diabetes. Diabetes Care 1999;22:137-40
- Graff MR, McClanahan MA. Assessment by patients with diabetes mellitus of two insulin pen delivery systems versus a vial and syringe. Clin Ther 1998;20:486-96
- Lee WC, Balu S, Cobden D, Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data. Clin Ther 2006;28:1712-25; discussion 0-1
- Lombardo F, Salzano G, Messina MF, Compliance and administration methods in management of type 1 diabetes. Acta Biomed 2005;76(Suppl 3):66-9
- Baser O, Bouchard J, DeLuzio T, Assessment of adherence and healthcare costs of insulin device (FlexPen) versus conventional vial/syringe. Adv Ther 2010;27:94-104
- Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care 2004;27:2495-7
- Asakura T, Seino H, Kageyama M, Dosing accuracy of two insulin pre-filled pens. Curr Med Res Opin 2008;24:1429-34
- Hanel H, Weise A, Sun W, Differences in the dose accuracy of insulin pens. J Diabetes Sci Tech 2008;2:478-81
- Pfutzner A, Reimer T, Frokjaer LPF, Prefilled insulin device with reduced injection force: patient perception and accuracy. Curr Med Res Opin 2008;24:2545-9
- Weise A, Pfutzner JW, Borig J, Comparison of the dose accuracy of prefilled insulin pens. J Diabetes Sci Tech 2009;3:149-53
- Asakura T, Seino H, Kageyama M, Evaluation of injection force of three insulin delivery pens. Expert Opin Pharmacother 2009;10:1389-93
- Rissler J, Jorgensen C, Rye Hansen M, Evaluation of injection force dynamics of a modified prefilled insulin pen. Expert Opin Pharmacother 2008;9:2217-22
- Frey MI, Barrett-Connor E, Sledge PA, The effect of noninsulin dependent diabetes mellitus on the prevalence of clinical osteoarthritis. A population based study. J Rheumatol 1996;23:716-22
- Savas S, Koroglu BK, Koyuncuoglu HR, The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic patients. Diabetes Res Clin Pract 2007;77:77-83
- Schady W, Abuaisha B, Boulton AJ. Observations on severe ulnar neuropathy in diabetes. J Diabetes Complications 1998;12:128-32
- Starkman HS, Gleason RE, Rand LI, Limited joint mobility (LJM) of the hand in patients with diabetes mellitus: relation to chronic complications. Ann Rheum Dis 1986;45:130-5
- Ziegler D, Gries FA, Spuler M, The epidemiology of diabetic neuropathy. DiaCAN Multicenter Study Group. Diabetes Med 1993;10(Suppl 2):82S-6S
- Hemmingsen H, Niemeyer M, Hansen MR, A prefilled insulin pen with a novel injection mechanism and a lower injection force than other prefilled insulin pens. Diabetes Technol Ther 2011;13: 10.1089/dia.2011.0110
- Wielandt JO, Niemeyer M, Hansen MR, FlexTouch: a prefilled insulin pen with a novel injection mechanism with consistent high accuracy at low- (1IU), medium- (40IU) and high- 80(IU) dose settings. J Diabetes Sci Technol 2011; In press
- ISO 11608-2. Pen needles for medical use - Part 2: Requirements and test methods
- Asakura T. Comparison of the dosing accuracy of two insulin injection devices. J Clin Res 2005;8:33-40
- Bohannon NJ. Insulin delivery using pen devices. Simple-to-use tools may help young and old alike. Postgrad Med 1999;106:57-8; 61-4, 8